Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
There's still too much risk in stock and bond markets. Earn this easy 4.5% return while you wait for stability, says trader who hit 2 big calls in 2022.
12:54pm, Thursday, 02'nd Feb 2023 MarketWatch
In our call of the day, LaDuc says cash is the place to be and that investors are "being paid to wait. They're getting very favorable 4.5% on their sitting cash."
Wall Street Breakfast Podcast: META Rockets
12:17pm, Thursday, 02'nd Feb 2023 Seeking Alpha
Meta Platforms rockets as Q4 results surpass expectations, unveils $40B buyback. Markets should 'feel better' by progress in debt limit talks - McCarthy. Crypto Thursday with Mike Fay.
Merck (MRK) Beats on Q4 Earnings & Sales, 2023 View Disappoints
12:02pm, Thursday, 02'nd Feb 2023
Merck (MRK) beats Q4 estimates for earnings and sales. Its 2023 profit guidance disappoints.
Merck & Co., Inc. (MRK) Q4 2022 Earnings Call Transcript
11:47am, Thursday, 02'nd Feb 2023
Merck & Co., Inc. (NYSE:MRK ) Q4 2022 Earnings Conference Call February 2, 2023 8:00 AM ET Company Participants Peter Dannenbaum - Vice President, Investor Relations Rob Davis - Chairman and CEO Carol
Merck delivers 4Q earnings beat but shares fall on 2023 outlook
11:26am, Thursday, 02'nd Feb 2023
Merck & Co Inc (NYSE:MRK) has delivered fourth-quarter revenue and earnings that beat expectations, supported by strong sales of its cancer immunotherapy Keytruda. However, shares of the Rahway, New
Merck Lands In Hot Water After 2023 Profit Guidance Widely Misses Forecasts
09:59am, Thursday, 02'nd Feb 2023
Merck's profit guidance for 2023 widely missed Wall Street's projections on Thursday, leading Merck stock to crumble despite a quarterly beat. The post Merck Lands In Hot Water After 2023 Profit Guida
Merck (MRK) Beats Q4 Earnings and Revenue Estimates
09:02am, Thursday, 02'nd Feb 2023
Merck (MRK) delivered earnings and revenue surprises of 3.85% and 0.65%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Merck beats earnings estimates
08:49am, Thursday, 02'nd Feb 2023
CNBC's Meg Tirrell reports on Merck's quarterly earnings results.
Merck stock falls after quarterly earnings top expectations but profit outlook disappoints
06:42am, Thursday, 02'nd Feb 2023
Shares of Merck & Co. Inc. MRK, -0.40% fell 0.9% in premarket trading Thursday, after the drug giant reported fourth-quarter results that beat expectations, but provided a full-year profit outlook tha
Why Merck & Co. (MRK) Might Surprise This Earnings Season
09:47am, Wednesday, 01'st Feb 2023
Merck & Co. (MRK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Checking in with Merck Stock Before Earnings
03:03pm, Tuesday, 31'st Jan 2023
Pharmaceutical company Merck & Co (NYSE:MRK) is one of the many big names set to announce its quarterly report this week, with earnings scheduled before the open on Thursday, Feb. 2.
Here's What To Expect From Merck's Q4
08:00am, Tuesday, 31'st Jan 2023
We expect MRK stock to trade sideways, with its revenue likely falling slightly below and earnings marginally above the street estimates.
Will This Billion-Dollar Acquisition Be a Smart Move for Merck?
10:07am, Friday, 27'th Jan 2023
Merck recently completed its acquisition of a California-based biotech company.
2 Market-Beating Stocks to Buy in 2023 and Hold for 10 Years
09:53am, Thursday, 26'th Jan 2023
These two healthcare giants defied the bear market last year.
